![]() |
市場調查報告書
商品編碼
2087689
獸用快速檢測市場:全球市場預測(依產品類型、目標動物、技術、應用、最終用戶和通路分類),2026-2032年Veterinary Rapid Test Market by Product Type, Animal Type, Technology, Application, End User, Distribution Channel - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,獸醫快速檢測市場將成長至 39 億美元,複合年成長率為 13.31%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 16.2億美元 |
| 預計年份:2026年 | 18.3億美元 |
| 預測年份 2032 | 39億美元 |
| 複合年成長率 (%) | 13.31% |
獸用快速檢測技術正從單純的便利工具發展成為動物健康、食品安全和通用感染疾病監測的第一線診斷方法。此類別包括跨流免疫檢測、快速酶聯免疫照護現場檢測和小型分析儀,用於檢測伴侶動物、牲畜、家禽和馬匹以及水產養殖中的病原體、抗體、激素、毒素和生物標記。
這項需求源自於公共衛生和農業領域面臨的特定挑戰。根據世界動物感染疾病(WOAH)統計,約60%的人類感染疾病為通用。同時,世界衛生組織(WHO)、聯合國糧農組織(FAO)和WOAH持續推動「同一健康」監測體系,將動物、人類和環境衛生系統連結起來。在此背景下,獸醫領域的快速診斷技術正幫助獸醫縮短治療時間,支持畜群層面的生物安全,減少不必要的抗生素使用,加強疫苗接種和篩檢計劃,並保護動物性食品供應鏈。
獸醫快速檢測的格局正在重塑,從集中式、依賴實驗室的檢查室轉向分散式、在診所、農場、收容所、邊境檢疫站和食品生產場所進行的即時檢測。這種轉變在感染疾病篩檢中最為明顯,因為快速決策對於犬細小病毒、貓白血病病毒、禽流感、牛呼吸道疾病、布氏桿菌症、乳腺炎、狂犬病監測和非洲豬瘟監測等疾病至關重要。
人工智慧透過改善結果解讀、實現工作流程自動化和加強疾病監測,提升了獸醫快速檢測的價值。人工智慧驅動的影像分析可以減少側向層析檢測結果解讀的主觀性,尤其是在弱陽性和臨界結果的情況下。此外,演算法決策支援可以將檢測結果與臨床症狀、疫苗接種史、地區、季節性、物種以及畜群或群體數據整合起來。
亞太地區因其龐大的牲畜存欄量、不斷成長的寵物護理支出、集約化的家禽和生豬養殖以及持續不斷的跨國動物疫病壓力,成為重點關注區域。中國和印度是牲畜和伴侶動物診斷領域的主要需求來源。同時,日本、韓國和澳洲則更重視品管控制的獸醫學、食品安全、生物安全和先進的即時檢測技術。在東協市場,隨著家禽、生豬、水產養殖和乳製品生產與出口標準和區域疾病監測計畫的接軌程度越來越高,快速檢測能力也不斷增強。
在東協,隨著各國政府加大對畜牧業生產力、水產養殖衛生管理以及家禽、豬、乳牛和養殖魚類疾病監測的投入,快速獸醫檢測的重要性日益凸顯。海灣合作理事會(GCC)市場的發展受到糧食安全戰略、進口限制、馬匹和駱駝健康管理計劃以及對可靠檢測的需求等因素的影響,這些因素有助於在炎熱、流動性強且醫療資源分散的環境下快速做出決策,遏制疾病傳播並支持動物流動管理。
美國憑藉其強大的伴侶動物獸醫網路、先進的畜牧生產系統以及在寵物主導、乳牛、豬、家禽和馬匹健康管理中廣泛應用即時診斷技術,在快速獸醫檢測領域處於領先地位。加拿大則強調動物健康監測、食品安全、合理使用抗菌藥物、地理分散式檢查。同時,墨西哥的需求也日益成長,這主要得益於伴侶動物照護、牲畜疾病管理以及跨境食品供應的整合。巴西在全球牛肉、家禽和豬肉出口領域扮演著重要角色,蘊藏著巨大的商機。這些因素共同推動了對快速篩檢、畜群健康管理工具、殘留物控制支援和疾病監測的需求。
產業領導者應優先考慮檢驗、易於使用且能在實際獸醫環境中(包括診所、農場、收容所、邊境檢疫站和現場監測計畫)提供可靠性能的快速檢測方法。產品系列應涵蓋伴侶動物的常見疾病,同時透過強大的試劑盒、清晰的診斷工具、耐高溫的包裝形式和便利的檢體採集流程,滿足牲畜、家禽、馬匹和水產養殖的生物安全需求。
本執行摘要基於二手資料研究和結構化市場分析編寫而成,所用資料包括經檢驗的資訊來源、監管文件、獸醫出版物、科學文獻、行業備案文件以及世界動物衛生組織(WOAH)、世界衛生組織(WHO)、食品藥物管理局(CDC)、美國農業部(USDA)、美國食品藥物管理局(FDA)、歐洲食品安全局(EFSA)、歐洲藥品管理局(EMA)和各國獸醫主管機關等機構提供的資料。本研究評估了疾病負擔、動物族群趨勢、診斷方法應用、監管要求、技術創新、終端用戶工作流程和商業性分銷模式。
獸用快速檢測市場正成為現代動物健康的重要戰略支柱,支持更快速的診斷、更早的干預、更強大的生物安全保障以及更負責任的治療決策。隨著「同一健康」概念日益重要,快速檢測在連接臨床診療、畜牧生產力、食品安全、合理使用抗菌藥物以及通用感染疾病監測方面發揮著至關重要的作用。
The Veterinary Rapid Test Market is projected to grow by USD 3.90 billion at a CAGR of 13.31% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 1.62 billion |
| Estimated Year [2026] | USD 1.83 billion |
| Forecast Year [2032] | USD 3.90 billion |
| CAGR (%) | 13.31% |
Veterinary rapid testing is moving from a convenience tool to a frontline diagnostic capability for animal health, food safety, and zoonotic disease surveillance. The category includes lateral flow immunoassays, rapid ELISA formats, point-of-care molecular assays, and compact analyzers used to detect pathogens, antibodies, hormones, toxins, and biomarkers in companion animals, livestock, poultry, equine care, and aquaculture.
Demand is supported by measurable public health and agricultural pressures. The World Organisation for Animal Health reports that around 60% of human infectious diseases are zoonotic, while WHO, FAO, and WOAH continue to promote One Health surveillance to connect animal, human, and environmental health systems. In this setting, rapid veterinary diagnostics help veterinarians shorten time to treatment, support herd-level biosecurity, reduce avoidable antimicrobial use, strengthen vaccination and screening programs, and protect animal-derived food supply chains.
The veterinary rapid test landscape is being reshaped by the shift from centralized, laboratory-only workflows toward decentralized point-of-care testing in clinics, farms, shelters, border inspection sites, and food production settings. This transformation is most visible in infectious disease screening, where fast decision-making is essential for conditions such as canine parvovirus, feline leukemia virus, avian influenza, bovine respiratory disease, brucellosis, mastitis, rabies surveillance, and African swine fever monitoring.
Another structural shift is the convergence of diagnostics, digital reporting, and preventive animal health programs. Veterinarians and producers increasingly require tests that are easy to administer, deliver actionable results in minutes, and integrate with electronic medical records or farm management systems. Regulatory expectations for traceability, residue control, antimicrobial resistance monitoring, and disease notification are also strengthening the role of validated rapid tests across the veterinary value chain.
Artificial intelligence is expanding the value of veterinary rapid testing by improving result interpretation, workflow automation, and disease surveillance. AI-enabled image analysis can reduce subjectivity in lateral flow test readings, particularly for weak-positive or borderline results, while algorithmic decision support can combine test outcomes with clinical signs, vaccination history, geography, seasonality, species, and herd or flock data.
The cumulative impact is broader than individual test performance. When rapid test data are digitized, AI can help identify outbreak clusters, assess disease risk, optimize inventory at clinics and farms, support quality control, and strengthen antimicrobial stewardship. These benefits are especially relevant as veterinary systems address emerging zoonoses, high-density livestock production, companion animal wellness programs, and the need for faster evidence-based treatment decisions.
Asia-Pacific is a high-priority region because of its large livestock population, rising pet care spending, intensive poultry and swine production, and recurring pressure from transboundary animal diseases. China and India represent substantial demand pools for livestock and companion animal diagnostics, while Japan, South Korea, and Australia emphasize quality-controlled veterinary care, food safety, biosecurity, and advanced point-of-care technologies. ASEAN markets are strengthening rapid testing capacity as poultry, swine, aquaculture, and dairy production become more integrated with export standards and regional disease surveillance programs.
North America remains a mature and innovation-led region, supported by extensive companion animal ownership, advanced veterinary clinics, producer-led herd health programs, and regulatory attention from agencies such as the USDA, FDA, and CFIA. Europe benefits from strong animal welfare regulation, EU surveillance frameworks, food chain controls, and veterinary antimicrobial stewardship initiatives. Latin America, led by Brazil and Mexico, is shaped by livestock export competitiveness, companion animal care expansion, and disease control requirements for beef, poultry, pork, and dairy value chains. The Middle East shows expanding need for portable and field-ready diagnostics as governments address food security, import inspection, equine health, camel health, and livestock mobility. Africa demonstrates increasing relevance for rapid veterinary diagnostics due to endemic and transboundary disease monitoring, pastoral livestock systems, and the need for practical tools in resource-variable field environments.
ASEAN is gaining relevance for veterinary rapid tests as regional governments invest in livestock productivity, aquaculture health, and surveillance for diseases affecting poultry, swine, dairy animals, and farmed fish. The GCC market is shaped by food security strategies, import controls, equine and camel health programs, and the need for reliable testing in hot, mobile, and distributed care environments where rapid decisions can reduce disease spread and support animal movement controls.
The European Union provides one of the most structured regulatory environments for veterinary diagnostics, with strong emphasis on animal welfare, food chain safety, disease notification, and antimicrobial resistance reduction. BRICS countries represent a broad demand base because they combine large animal populations, fast-growing protein consumption, livestock intensification, and expanding veterinary infrastructure. G7 markets are generally characterized by premium companion animal care, high diagnostic adoption, established laboratory networks, and faster uptake of digital point-of-care systems, while NATO countries benefit from coordinated biosecurity awareness, especially around zoonotic risk, livestock disease preparedness, border health security, and resilience of critical food supply systems.
The United States leads in veterinary rapid test adoption through a strong companion animal clinic network, advanced livestock production systems, and broad use of point-of-care diagnostics across pet care, dairy, swine, poultry, and equine health. Canada emphasizes animal health surveillance, food safety, antimicrobial stewardship, and distributed testing across large geographies, while Mexico is expanding demand through companion animal care, livestock disease management, and cross-border food supply integration. Brazil is a major opportunity due to its global role in beef, poultry, and pork exports, which increases the need for rapid screening, herd health tools, residue control support, and disease surveillance.
In Europe, the United Kingdom, Germany, France, Italy, and Spain support demand through established veterinary services, high pet ownership, livestock traceability, animal welfare standards, and antimicrobial stewardship. Russia's large geography and livestock base create need for field-deployable testing to support regional disease monitoring and farm-level decision-making. China and India are central to Asia-Pacific development because of their large animal populations, expanding protein consumption, and increasing veterinary service penetration, while Japan and South Korea favor high-quality diagnostic platforms for companion animals, livestock health, and food safety. Australia's biosecurity priorities, disease-free status protection, and export-oriented livestock sector reinforce the value of validated rapid tests across farms, clinics, and surveillance programs.
Industry leaders should prioritize validated, easy-to-use rapid tests that deliver reliable performance in real-world veterinary settings, including clinics, farms, shelters, border control points, and field surveillance programs. Product portfolios should address high-volume diseases in companion animals while also supporting livestock, poultry, equine, and aquaculture biosecurity needs through ruggedized kits, clear interpretation tools, temperature-stable formats, and practical sample collection workflows.
Commercial strategy should combine distributor depth with clinician education, digital result capture, quality assurance, and technical support. Companies that integrate rapid tests with tele-veterinary workflows, herd management software, laboratory information systems, and AI-assisted analytics will be better positioned to demonstrate measurable value in faster treatment, reduced production losses, responsible antimicrobial use, stronger compliance, and outbreak preparedness.
This executive summary is developed through secondary research and structured market analysis using verified public sources, regulatory references, veterinary health publications, scientific literature, industry filings, and institutional data from organizations such as WOAH, WHO, FAO, CDC, USDA, FDA, EFSA, EMA, and national veterinary authorities. The research framework evaluates disease burden, animal population trends, diagnostic adoption, regulatory requirements, technology innovation, end-user workflows, and commercial distribution patterns.
Insights are triangulated across regional demand indicators, product category trends, end-user behavior, public health priorities, biosecurity programs, and documented animal disease surveillance needs. The methodology emphasizes data reliability, source consistency, and practical relevance for veterinary rapid test manufacturers, distributors, investors, veterinarians, producers, and animal health decision-makers, without relying on unverified projections or speculative sizing assumptions.
The veterinary rapid test market is becoming a strategic pillar of modern animal health because it supports faster diagnosis, earlier intervention, stronger biosecurity, and more responsible treatment decisions. As One Health priorities intensify, rapid tests are increasingly important for connecting clinical care, livestock productivity, food safety, antimicrobial stewardship, and zoonotic disease surveillance.
Future competitiveness will depend on accuracy, usability, affordability, field robustness, regulatory alignment, and digital integration. Organizations that combine validated assays with AI-enabled interpretation, regional disease expertise, practical training, and scalable distribution models will be well positioned to serve demand across companion animal clinics, livestock systems, aquaculture operations, border inspection programs, and public health surveillance networks.